15 upcoming neuro-exosome trials set to change dementia care in 2026
As we enter 2026, the global medical community is laser-focused on the results of several pivotal Phase IIb trials involving exosomes engineered for intracranial delivery. In Switzerland and Japan, researchers have reported the first successful use of "homing" vesicles that selectively target amyloid plaques in the brain without causing the neuro-inflammation often seen in monoclonal antibody...
0 Comments 0 Shares 188 Views 0 Reviews
Sponsored